Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Exp Hematol

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    August 2018
  1. BORGES CS, Ferreira AF, Almeida VH, Gomes FG, et al
    CROSSTALK BETWEEN BCR-ABL AND PROTEASE-ACTIVATED RECEPTOR 1 (PAR1) SUGGESTS A NOVEL TARGET IN CHRONIC MYELOID LEUKEMIA.
    Exp Hematol. 2018 Aug 1. pii: S0301-472X(18)30746.
    PubMed     Text format     Abstract available


    July 2018
  2. KOTB A, Fakih RE, Hanbali A, Hawsawi Y, et al
    Philadelphia-Like Acute Lymphoblastic Leukemia: Diagnostic dilemma and management perspectives.
    Exp Hematol. 2018 Jul 31. pii: S0301-472X(18)30743.
    PubMed     Text format     Abstract available


    May 2018
  3. NICOLINI FE, Alcazer V, Cony-Makhoul P, Heiblig M, et al
    Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on imatinib first-line.
    Exp Hematol. 2018 May 22. pii: S0301-472X(18)30259.
    PubMed     Text format     Abstract available


  4. SHI X, Kitano A, Jiang Y, Luu V, et al
    Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells.
    Exp Hematol. 2018 May 8. pii: S0301-472X(18)30256.
    PubMed     Text format     Abstract available


  5. JENKINS CE, Gusscott S, Wong RJ, Shevchuk OO, et al
    RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.
    Exp Hematol. 2018 May 4. pii: S0301-472X(18)30217.
    PubMed     Text format     Abstract available


  6. DESTERKE C, Voldoire M, Bonnet ML, Sorel N, et al
    Experimental and integrative analyses identify an ETS1 network downstream BCR-ABL in chronic myeloid leukemia (CML).
    Exp Hematol. 2018 May 4. pii: S0301-472X(18)30216.
    PubMed     Text format     Abstract available


    April 2018
  7. THURGOOD LA, Lower KM, Macardle C, Kuss BJ, et al
    Aberrant detection of phenotypic markers in chronic lymphocytic leukemia (CLL) lymphocytes following cryopreservation.
    Exp Hematol. 2018 Apr 26. pii: S0301-472X(18)30172.
    PubMed     Text format     Abstract available


    March 2018
  8. NEWCOMBE AA, Gibson BES, Keeshan K
    Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
    Exp Hematol. 2018 Mar 30. pii: S0301-472X(18)30166.
    PubMed     Text format     Abstract available


  9. ORTI G, Sanz J, Garcia-Cadenas I, Sanchez-Ortega I, et al
    Analysis of relapse post transplant in acute leukemia, a comparative on second allogeneic hematopoietic cell transplant and donor lymphocyte infusions.
    Exp Hematol. 2018 Mar 8. pii: S0301-472X(18)30120.
    PubMed     Text format     Abstract available


    February 2018
  10. ZYLBERSZTEJN F, Flores-Violante M, Voeltzel T, Nicolini FE, et al
    The BMP pathway: a unique tool to decode origin and progression of leukemia.
    Exp Hematol. 2018 Feb 22. pii: S0301-472X(18)30077.
    PubMed     Text format     Abstract available


  11. LI H, Xing C, Zhou B, Ye H, et al
    A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.
    Exp Hematol. 2018 Feb 13. pii: S0301-472X(18)30041.
    PubMed     Text format     Abstract available


    January 2018
  12. GONG Y, Zhao M, Yang W, Gao A, et al
    Megakaryocyte-derived excessive TGFbeta1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia.
    Exp Hematol. 2018 Jan 4. pii: S0301-472X(17)30909.
    PubMed     Text format     Abstract available


    December 2017
  13. GRIESSINGER E, Vargaftig J, Horswell S, Taussig DC, et al
    Acute myeloid leukemia xenograft success prediction: saving time.
    Exp Hematol. 2017 Dec 15. pii: S0301-472X(17)30900.
    PubMed     Text format     Abstract available


    November 2017
  14. CASTAGNA L, Devillier R, Vey N, Blaise D, et al
    T cell replete-haploidentical transplantation in acute myeloid leukemia.
    Exp Hematol. 2017 Nov 16. pii: S0301-472X(17)30861.
    PubMed     Text format     Abstract available


  15. CULL AH, Snetsinger B, Buckstein R, Wells RA, et al
    Tet2 restrains inflammatory gene expression in macrophages.
    Exp Hematol. 2017;55:56-70.
    PubMed     Text format     Abstract available


    October 2017
  16. BOILA LD, Chatterjee SS, Banerjee D, Sengupta A, et al
    KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia.
    Exp Hematol. 2017 Oct 27. pii: S0301-472X(17)30824.
    PubMed     Text format     Abstract available


  17. WILLMANN M, Sadovnik I, Eisenwort G, Entner M, et al
    Evaluation of cooperative anti-leukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia.
    Exp Hematol. 2017 Oct 12. pii: S0301-472X(17)30816.
    PubMed     Text format     Abstract available


  18. HASSAN C, Afshinnekoo E, Li S, Wu S, et al
    Genetic and epigenetic heterogeneity and the impact on cancer relapse.
    Exp Hematol. 2017;54:26-30.
    PubMed     Text format     Abstract available


    September 2017
  19. GREGORY MA, Nemkov T, Reisz JA, Zaberezhnyy V, et al
    Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
    Exp Hematol. 2017 Sep 22. pii: S0301-472X(17)30776.
    PubMed     Text format     Abstract available


  20. LAGACE K, Barabe F, Hebert J, Cellot S, et al
    Identification of novel biomarkers for MLL translocated acute myeloid leukemia.
    Exp Hematol. 2017 Sep 11. pii: S0301-472X(17)30758.
    PubMed     Text format     Abstract available


  21. CHAN LN, Muschen M
    B-cell identity as a metabolic barrier against malignant transformation.
    Exp Hematol. 2017;53:1-6.
    PubMed     Text format     Abstract available


    August 2017
  22. HEROLD N, Rudd SG, Sanjiv K, Kutzner J, et al
    With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.
    Exp Hematol. 2017;52:32-39.
    PubMed     Text format     Abstract available


  23. KIM YM, Gang EJ, Kahn M
    CBP/Catenin antagonists: Targeting LSCs' Achilles heel.
    Exp Hematol. 2017;52:1-11.
    PubMed     Text format     Abstract available


    July 2017
  24. ZHANG J, Griffith M, Miller CA, Griffith OL, et al
    Comprehensive discovery of non-coding RNAs in acute myeloid leukemia cell transcriptomes.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30701.
    PubMed     Text format     Abstract available


  25. YALCIN A, Kovarbasic M, Wehrle J, Claus R, et al
    The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30702.
    PubMed     Text format     Abstract available


  26. MARTINO B, Mammi C, Labate C, Rodi S, et al
    Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30663.
    PubMed     Text format     Abstract available


  27. CARRETTA M, de Boer B, Jaques J, Antonelli A, et al
    Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Exp Hematol. 2017;51:36-46.
    PubMed     Text format     Abstract available


  28. LEPRETRE S, Graux C, Touzart A, Macintyre E, et al
    Adult T-type lymphoblastic lymphoma: Treatment advances and prognostic indicators.
    Exp Hematol. 2017;51:7-16.
    PubMed     Text format     Abstract available


    June 2017
  29. LAING AA, Harrison CJ, Gibson BES, Keeshan K, et al
    Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
    Exp Hematol. 2017 Jun 28. pii: S0301-472X(17)30237.
    PubMed     Text format     Abstract available


  30. SANDA T, Leong WZ
    TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
    Exp Hematol. 2017 Jun 23. pii: S0301-472X(17)30231.
    PubMed     Text format     Abstract available


  31. SLOMA I, Mitjavila-Garcia M, Feraud O, Griscelli F, et al
    Whole genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.
    Exp Hematol. 2017 Jun 7. pii: S0301-472X(17)30192.
    PubMed     Text format     Abstract available


  32. PORTER SN, Magee JA
    PRKCH regulates hematopoietic stem cell function and predicts poor prognosis in acute myeloid leukemia.
    Exp Hematol. 2017 Jun 5. pii: S0301-472X(17)30190.
    PubMed     Text format     Abstract available


    May 2017
  33. OMORI I, Yamaguchi H, Miyake K, Miyake N, et al
    D816V mutation in the KIT gene activation loop has a greater cell proliferative and anti-apoptotic ability than N822K mutation in core binding factor-acute myeloid leukemia.
    Exp Hematol. 2017 May 12. pii: S0301-472X(17)30146.
    PubMed     Text format     Abstract available


  34. SHEN Y, Chen TJ, Lacorazza HD
    Novel tumor suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.
    Exp Hematol. 2017 May 4. pii: S0301-472X(17)30141.
    PubMed     Text format     Abstract available


    April 2017
  35. SADOVNIK I, Herrmann H, Eisenwort G, Blatt K, et al
    Expression of CD25 on Leukemic Stem Cells in BCR-ABL1+ CML: Potential Diagnostic Value and Functional Implications.
    Exp Hematol. 2017 Apr 27. pii: S0301-472X(17)30135.
    PubMed     Text format     Abstract available


  36. VAN GILS N, Verhagen HJMP, Smit L
    Reprogramming acute myeloid leukemia into sensitivity for retinoic acid-driven differentiation.
    Exp Hematol. 2017 Apr 26. pii: S0301-472X(17)30139.
    PubMed     Text format     Abstract available


  37. SASAKI T, Rivera-Mulia JC, Vera D, Zimmerman J, et al
    Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia.
    Exp Hematol. 2017 Apr 19. pii: S0301-472X(17)30136.
    PubMed     Text format     Abstract available


  38. CHOI EJ, Kim MS, Yoo NJ, Lee SH, et al
    Mutational analysis of hypermutation-related POLE gene in acute leukemias and lymphomas.
    Exp Hematol. 2017;48:39-40.
    PubMed     Text format    


    March 2017
  39. GHOSH J, Kapur R
    Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
    Exp Hematol. 2017 Mar 22. pii: S0301-472X(17)30063.
    PubMed     Text format     Abstract available


  40. CLARKE CJ, Holyoake TL
    Preclinical approaches in chronic myeloid leukemia: from cells to systems.
    Exp Hematol. 2017;47:13-23.
    PubMed     Text format     Abstract available


  41. UTTARKAR S, Frampton J, Klempnauer KH
    Targeting the transcription factor Myb by small-molecule inhibitors.
    Exp Hematol. 2017;47:31-35.
    PubMed     Text format     Abstract available


  42. BOGEN A, Buske C, Hiddemann W, Bohlander SK, et al
    Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
    Exp Hematol. 2017;47:54-63.
    PubMed     Text format     Abstract available


    February 2017
  43. CAO H, Xu Y, de Necochea-Campion R, Baylink DJ, et al
    Application of vitamin D and vitamin D analogs in acute myelogenous leukemia.
    Exp Hematol. 2017 Feb 4. pii: S0301-472X(17)30050.
    PubMed     Text format     Abstract available


  44. YOKOYAMA A
    Transcriptional activation by MLL fusion proteins in leukemogenesis.
    Exp Hematol. 2017;46:21-30.
    PubMed     Text format     Abstract available


    January 2017
  45. CANDONI A, De Marchi F, Zanini F, Zannier ME, et al
    Predictive value of pre transplant molecular minimal residual disease assessment by wt1 gene expression in flt3 positive acute myeloid leukemia.
    Exp Hematol. 2017 Jan 31. pii: S0301-472X(17)30015.
    PubMed     Text format     Abstract available


  46. AN X, Liu J, Wang N, Wang D, et al
    AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes.
    Exp Hematol. 2017;45:36-44.
    PubMed     Text format     Abstract available


    December 2016
  47. ORTI G, Barba P, Fox L, Salamero O, et al
    Donor Lymphocyte Infusions in AML and MDS: enhancing the Graft-versus-Leukemia effect.
    Exp Hematol. 2016 Dec 24. pii: S0301-472X(16)30772.
    PubMed     Text format    


    November 2016
  48. CHURCHMAN ML, Mullighan CG
    Ikaros: exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.
    Exp Hematol. 2016 Nov 16. pii: S0301-472X(16)30703.
    PubMed     Text format     Abstract available


  49. ZHOU X, Li Z, Zhou J
    TNF-alpha in onset and progression of leukemia.
    Exp Hematol. 2016 Nov 7. pii: S0301-472X(16)30660.
    PubMed     Text format     Abstract available


  50. LEMOLI RM, Parisi S, Curti A
    Novel Strategies of Adoptive Immunotherapy: How Natural Killer Cells May Change the Treatment of Elderly Patients With Acute Myeloblastic Leukemia.
    Exp Hematol. 2016 Nov 5. pii: S0301-472X(16)30662.
    PubMed     Text format     Abstract available


    October 2016
  51. DWIVEDI P, Greis KD
    Granulocyte Colony Stimulating Factor Receptor (G-CSFR) signaling in severe congenital neutropenia, chronic neutrophilic leukemia and related malignancies.
    Exp Hematol. 2016 Oct 24. pii: S0301-472X(16)30663.
    PubMed     Text format     Abstract available


  52. ZHOU L, Wang Q, Chen X, Fu L, et al
    AML1-ETO promotes SIRT1 expression to enhance leukemogenesis of t(8;21) acute myeloid leukemia.
    Exp Hematol. 2016 Oct 7. pii: S0301-472X(16)30649.
    PubMed     Text format     Abstract available


  53. DEVEAU AP, Bentley VL, Berman JN
    Using zebrafish models of leukemia to streamline drug screening and discovery.
    Exp Hematol. 2016 Oct 6. pii: S0301-472X(16)30648.
    PubMed     Text format     Abstract available


    September 2016
  54. YANAGISAWA B, Ghiaur G, Smith BD, Jones RJ, et al
    Translating Leukemia Stem Cells into the Clinic: Harmonizing the Heterogeneity.
    Exp Hematol. 2016 Sep 28. pii: S0301-472X(16)30572.
    PubMed     Text format     Abstract available


  55. BASHFORD-ROGERS RJ, Palser AL, Hodkinson C, Baxter J, et al
    Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.
    Exp Hematol. 2016 Sep 28. pii: S0301-472X(16)30622.
    PubMed     Text format     Abstract available


  56. PARK M, Park CJ, Cho YW, Jang S, et al
    Alterations in bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia and normal bone marrow.
    Exp Hematol. 2016 Sep 27. pii: S0301-472X(16)30621.
    PubMed     Text format     Abstract available


  57. WEIDEMANN RR, Behrendt R, Schoedel KB, Muller W, et al
    Constitutive Kit activity triggers B cell acute lymphoblastic leukemia-like disease in mice.
    Exp Hematol. 2016 Sep 21. pii: S0301-472X(16)30615.
    PubMed     Text format     Abstract available


  58. SCHNEIDER E, Staffas A, Rohner L, Krowiorz K, et al
    MicroRNA-155 is upregulated in MLL rearranged AML but its absence does not affect leukemia development.
    Exp Hematol. 2016 Sep 9. pii: S0301-472X(16)30597.
    PubMed     Text format     Abstract available


    July 2016
  59. LAVERDIERE I, Boileau M, Herold T, Rak J, et al
    Complement Cascade Gene Expression Defines Novel Prognostic Subgroups of Acute Myeloid Leukemia.
    Exp Hematol. 2016 Jul 26. pii: S0301-472X(16)30514.
    PubMed     Text format    


  60. RUCKER-BRAUN E, Link CS, Schmiedgen M, Tunger A, et al
    Longitudinal analyses of leukemia-associated antigen-specific CD8+ T cells in patients after allogeneic stem cell transplantation.
    Exp Hematol. 2016 Jul 26. pii: S0301-472X(16)30510.
    PubMed     Text format     Abstract available


  61. ZHAO L, Eric So CW
    PARP-inhibitor-induced synthetic lethality for acute myeloid leukemia treatment.
    Exp Hematol. 2016 Jul 26. pii: S0301-472X(16)30509.
    PubMed     Text format     Abstract available


    June 2016
  62. KOJIMA K, Ishizawa J, Andreeff M
    Pharmacological activation of wild-type p53 in the therapy of leukemia.
    Exp Hematol. 2016 Jun 17. pii: S0301-472X(16)30139.
    PubMed     Text format     Abstract available


    May 2016
  63. ECKSTEIN OS, Wang L, Punia JN, Kornblau SM, et al
    Mixed Phenotype Acute Leukemia (MPAL) Exhibits Frequent Mutations in DNMT3A and Activated Signaling Genes.
    Exp Hematol. 2016 May 18. pii: S0301-472X(16)30128.
    PubMed     Text format     Abstract available


  64. GRIFFITH M, Griffith OL, Krysiak K, Skidmore ZL, et al
    Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B lymphoblastic leukemia.
    Exp Hematol. 2016 May 12. pii: S0301-472X(16)30115.
    PubMed     Text format     Abstract available


  65. TESTA U, Labbaye C, Castelli G, Pelosi E, et al
    Oxidative Stress and Hypoxia in Normal and Leukemic Stem Cells.
    Exp Hematol. 2016 May 11. pii: S0301-472X(16)30116.
    PubMed     Text format     Abstract available


  66. KADONO M, Kanai A, Nagamachi A, Shinriki S, et al
    Biological implications of somatic DDX41 p.R525H mutation in acute myeloid leukemia.
    Exp Hematol. 2016 May 9. pii: S0301-472X(16)30125.
    PubMed     Text format     Abstract available


  67. ZHANG J, Liu X, Lin Y, Li Y, et al
    HnRNP K contributes to drug resistance in acute myeloid leukemia through the regulation of autophagy.
    Exp Hematol. 2016 May 4. pii: S0301-472X(16)30118.
    PubMed     Text format     Abstract available


  68. YANG YG, Sari IN, Zia MF, Lee SR, et al
    Tetraspanins: Spanning from solid tumors to hematologic malignancies.
    Exp Hematol. 2016;44:322-8.
    PubMed     Text format     Abstract available


  69. BOSSE RC, Wasserstrom B, Meacham A, Wise E, et al
    Chemosensitizing AML cells by targeting bone marrow endothelial cells.
    Exp Hematol. 2016;44:363-377.
    PubMed     Text format     Abstract available


    April 2016
  70. RIEGER CT, Fiegl M
    Microenvironmental oxygen partial pressure in acute myeloid leukemia: is there really a role for hypoxia?
    Exp Hematol. 2016 Apr 23. pii: S0301-472X(16)30082.
    PubMed     Text format     Abstract available


  71. BYRNE M, Savani BN, Mohty M, Nagler A, et al
    Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Exp Hematol. 2016 Apr 19. pii: S0301-472X(16)30077.
    PubMed     Text format     Abstract available


    March 2016
  72. WANG QY, Zhong H, Chen FY, Zhang MY, et al
    A preliminary study on epigenetic regulation of Acanthopanax senticosus in leukemia cell lines.
    Exp Hematol. 2016 Mar 15. pii: S0301-472X(16)30031.
    PubMed     Text format     Abstract available


  73. HOOFD C, Wang X, Lam S, Jenkins C, et al
    CD44 promotes chemoresistance in T-ALL by increased drug efflux.
    Exp Hematol. 2016;44:166-71.
    PubMed     Text format     Abstract available


  74. ISHIBASHI T, Yaguchi A, Terada K, Ueno-Yokohata H, et al
    Ph-like ALL-related novel fusion kinase ATF7IP-PDGFRB exhibits high sensitivity to tyrosine kinase inhibitors in murine cells.
    Exp Hematol. 2016;44:177-88.
    PubMed     Text format     Abstract available


    February 2016
  75. KUO YH, Qi J, Cook GJ
    Regain control of p53: targeting leukemia stem cells by isoform-specific HDAC inhibition.
    Exp Hematol. 2016 Feb 25. pii: S0301-472X(16)00071.
    PubMed     Text format     Abstract available


  76. CERABONA D, Sun Z, Nalepa G
    Leukemia and chromosomal instability in aged Fancc-/- mice.
    Exp Hematol. 2016 Feb 6. pii: S0301-472X(16)00038.
    PubMed     Text format     Abstract available


  77. PIZZO RJ, Azadniv M, Guo N, Acklin J, et al
    Phenotypic, Genotypic, and Functional Characterization of Normal and Acute Myeloid Leukemia-Derived Marrow Endothelial Cells.
    Exp Hematol. 2016 Feb 3. pii: S0301-472X(16)00037.
    PubMed     Text format     Abstract available


  78. SCHMOHL J, Santovito D, Guenther T, Sutanto W, et al
    Expression of surface-associated 82kDa-proMMP-9 in primary acute leukemia blast cells inversely correlates with patients' risk.
    Exp Hematol. 2016 Feb 1. pii: S0301-472X(16)00036.
    PubMed     Text format     Abstract available


    January 2016
  79. CHEN WS, Zhu HH, Feng GS
    Treating Leukemia at Risk of Inducing Severe Anemia.
    Exp Hematol. 2016 Jan 27. pii: S0301-472X(16)00033.
    PubMed     Text format     Abstract available


  80. ISHIBASHI T, Yokota T, Tanaka H, Ichii M, et al
    ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.
    Exp Hematol. 2016 Jan 13. pii: S0301-472X(16)00005.
    PubMed     Text format     Abstract available


    December 2015
  81. SUN WT, Xiang W, Ng BL, Asari K, et al
    Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia.
    Exp Hematol. 2015 Dec 17. pii: S0301-472X(15)00799.
    PubMed     Text format     Abstract available


  82. DOLNIKOV A, Shen S, Klamer G, Joshi S, et al
    Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia.
    Exp Hematol. 2015;43:1001-1014.
    PubMed     Text format     Abstract available


    November 2015
  83. TZORAN I, Rebibo-Sabbah A, Brenner B, Aharon A, et al
    Disease dynamics in patients with acute myeloid leukemia: new biomarkers.
    Exp Hematol. 2015;43:936-43.
    PubMed     Text format     Abstract available


  84. NAKAMURA D, Yoshimitsu M, Kuroki A, Hachiman M, et al
    A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent.
    Exp Hematol. 2015;43:944-50.
    PubMed     Text format     Abstract available


  85. DANIS E, Yamauchi T, Echanique K, Haladyna J, et al
    Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model.
    Exp Hematol. 2015;43:930-935.
    PubMed     Text format     Abstract available


    October 2015
  86. MANUKJAN G, Ripperger T, Santer L, von Neuhoff N, et al
    Expression of the ETS transcription factor GABPalpha is positively correlated to the BCR-ABL1/ABL1 ratio in CML patients and affects imatinib sensitivity in vitro.
    Exp Hematol. 2015;43:880-90.
    PubMed     Text format     Abstract available


  87. KING KY, Matatall KA, Shen CC, Goodell MA, et al
    Comparative long-term effects of interferon alpha and hydroxyurea on human hematopoietic progenitor cells.
    Exp Hematol. 2015;43:912-918.
    PubMed     Text format     Abstract available


    September 2015
  88. SAUER T, Arteaga MF, Isken F, Rohde C, et al
    MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AML.
    Exp Hematol. 2015;43:794-802.
    PubMed     Text format     Abstract available


  89. CHAUDHURY SS, Morison JK, Gibson BE, Keeshan K, et al
    Insights into cell ontogeny, age, and acute myeloid leukemia.
    Exp Hematol. 2015;43:745-55.
    PubMed     Text format     Abstract available


    May 2015
  90. IIZUKA H, Kagoya Y, Kataoka K, Yoshimi A, et al
    Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
    Exp Hematol. 2015 May 25. pii: S0301-472X(15)00170.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: